## **Core Concept**
The patient's history of chronic corticosteroid therapy is crucial. Long-term corticosteroid use is associated with several metabolic bone diseases due to its effects on bone formation and resorption. Corticosteroids can lead to decreased bone formation by inhibiting osteoblast function and increased bone resorption.

## **Why the Correct Answer is Right**
The patient's presentation with hip pain and a history of chronic corticosteroid therapy for severe asthma most likely points towards **osteoporosis**. Osteoporosis is characterized by a decrease in bone mass and density, leading to an increased risk of fractures. Corticosteroids promote the excretion of calcium in the urine, decrease calcium absorption in the gut, and directly affect bone cells, leading to a net loss of bone mass over time. This condition is a well-known complication of long-term corticosteroid therapy.

## **Why Each Wrong Option is Incorrect**
- **Option A:** While **osteomalacia** is a metabolic bone disease, it is primarily caused by a deficiency of vitamin D and calcium, leading to softening of the bones. It is less directly associated with corticosteroid use compared to osteoporosis.
- **Option B:** **Paget's disease of bone** is a condition characterized by an abnormal breakdown and regrowth of bone tissue, leading to deformities. It is not directly caused by corticosteroid therapy.
- **Option D:** **Primary hyperparathyroidism** involves an overproduction of parathyroid hormone, leading to hypercalcemia and its effects on bone. This condition is not a direct consequence of corticosteroid therapy.

## **Clinical Pearl / High-Yield Fact**
A key clinical pearl is that patients on chronic corticosteroid therapy should be considered for preventive measures against osteoporosis, such as bisphosphonates, vitamin D and calcium supplements, and lifestyle modifications. Early intervention can significantly reduce the risk of osteoporotic fractures.

## **Correct Answer Line**
**Correct Answer: C. Osteoporosis**